Microparticle-based technologies for vaccines

被引：123

作者：

O'Hagan, Derek T. ^{[1
]}

Singh, Manmohan ^{[1
]}

Ulmer, Jeffrey B. ^{[1
]}

机构：

[1] Novartis Vaccines & Diagnost Inc, Vaccines Res, Emeryville, CA 94608 USA

来源：

METHODS | 2006年 / 40卷 / 01期

关键词：

adjuvants; delivery systems; innate immunity; toll-like receptors; antibodies; helper T lymphocytes; cytotoxic T lymphocytes;

D O I：

10.1016/j.ymeth.2006.05.017

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Microparticles have been effectively used for many years as delivery systems for drugs and therapeutic proteins. Their application to the delivery of vaccines is not as extensive, but is growing. Utility has been demonstrated for the delivery of various types of vaccines (e.g., recombinant proteins, plasmid DNA, and peptides) and other vaccine components (e.g., immune potentiators). With respect to delivery of immune potentiators, synergistic effects are often observed whereby much more potent immune responses are induced with a combination than with either component alone. Hence, the prospects for broad application of microparticle-based delivery systems for vaccines are excellent. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：10 / 19

页数：10

共 133 条

[91] Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara [J].

Schneider, J ;

Gilbert, SC ;

Blanchard, TJ ;

Hanke, T ;

Robson, KJ ;

Hannan, CM ;

Becker, M ;

Sinden, R ;

Smith, GL ;

Hill, AVS .

NATURE MEDICINE, 1998, 4 (04) :397-402

[92] STABILIZATION OF TETANUS AND DIPHTHERIA TOXOIDS AGAINST MOISTURE-INDUCED AGGREGATION [J].

SCHWENDEMAN, SP ;

COSTANTINO, HR ;

GUPTA, RK ;

SIBER, GR ;

KLIBANOV, AM ;

LANGER, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11234-11238

[93] DNA vaccines - Designer vaccines for the 21st Century [J].

Seder, RA ;

Gurunathan, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :277-278

[94] Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin A encapsulated in microspheres [J].

Seo, JY ;

Seong, SY ;

Ahn, BY ;

Kwon, IC ;

Chung, H ;

Jeong, SY .

INFECTION AND IMMUNITY, 2002, 70 (03) :1143-1149

[95] ADJUVANTICITY AND PROTECTIVE IMMUNITY ELICITED BY BORDETELLA-PERTUSSIS ANTIGENS ENCAPSULATED IN POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].

SHAHIN, R ;

LEEF, M ;

ELDRIDGE, J ;

HUDSON, M ;

GILLEY, R .

INFECTION AND IMMUNITY, 1995, 63 (04) :1195-1200

[96] Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres [J].

Shi, L ;

Caulfield, MJ ;

Chern, RT ;

Wilson, RA ;

Sanyal, G ;

Volkin, DB .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (04) :1019-1035

[97]

Shi Y, 2002, EUR J IMMUNOL, V32, P155, DOI 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO

[98]

2-P

[99] Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice [J].

Singh, M ;

Li, XM ;

McGee, JP ;

Zamb, T ;

Koff, W ;

Wang, CY ;

OHagan, DT .

VACCINE, 1997, 15 (05) :475-481

[100] Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not [J].

Singh, M ;

Chesko, J ;

Kazzaz, J ;

Ugozzoli, M ;

Kan, E ;

Srivastava, I ;

O'Hagan, DT .

PHARMACEUTICAL RESEARCH, 2004, 21 (12) :2148-2152

← 5 6 7 8 9 10 11 12 13 14 →